GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 2 filers reported holding GW PHARMACEUTICALS PLC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,137,000 | +79.3% | 5,240 | -4.6% | 0.18% | +89.6% |
| Q4 2020 | $634,000 | +9.7% | 5,490 | -7.6% | 0.10% | +10.3% |
| Q3 2020 | $578,000 | -23.3% | 5,940 | -3.3% | 0.09% | -23.0% |
| Q2 2020 | $754,000 | +28.4% | 6,140 | -8.4% | 0.11% | -10.3% |
| Q1 2020 | $587,000 | -7.0% | 6,700 | +11.0% | 0.13% | +3.3% |
| Q4 2019 | $631,000 | -6.8% | 6,035 | +2.5% | 0.12% | -14.7% |
| Q3 2019 | $677,000 | -28.4% | 5,885 | +7.3% | 0.14% | -30.9% |
| Q2 2019 | $946,000 | -0.4% | 5,485 | -2.7% | 0.21% | -19.1% |
| Q1 2019 | $950,000 | +72.7% | 5,635 | -0.3% | 0.26% | +61.0% |
| Q4 2018 | $550,000 | -23.8% | 5,650 | +35.2% | 0.16% | -17.2% |
| Q3 2018 | $722,000 | +59.4% | 4,180 | +28.8% | 0.19% | +43.3% |
| Q2 2018 | $453,000 | +60.1% | 3,245 | +29.3% | 0.13% | +54.0% |
| Q1 2018 | $283,000 | -6.0% | 2,510 | +10.1% | 0.09% | -5.4% |
| Q4 2017 | $301,000 | +46.8% | 2,280 | +12.9% | 0.09% | +33.3% |
| Q3 2017 | $205,000 | – | 2,020 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 3,455,054 | $456,102,000 | 8.18% |
| Consonance Capital Management LP | 675,492 | $89,172,000 | 8.05% |
| Prisma Capital Partners LP | 33,000 | $4,356,000 | 4.11% |
| Broadfin Capital, LLC | 122,930 | $16,228,000 | 2.65% |
| Rock Springs Capital Management LP | 354,000 | $46,732,000 | 2.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 339,180 | $44,775,000 | 1.76% |
| GREAT POINT PARTNERS LLC | 75,000 | $9,901,000 | 1.69% |
| Atika Capital Management LLC | 31,000 | $4,092,000 | 1.58% |
| Sivik Global Healthcare LLC | 30,000 | $3,960,000 | 1.47% |
| Sio Capital Management, LLC | 19,000 | $2,508,000 | 1.41% |